Skip to content
healthcare.dev

Regadenoson

NDC 71288-201, Regadenoson, injection, solution, from Meitheal Pharmaceuticals Inc..

Product NDC
71288-201
Status
Listed
Labeler
Meitheal Pharmaceuticals Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212806
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71288-201 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • REGADENOSON.08 mg/mL

Pharmacologic classes

Adenosine Receptor Agonists [MoA]; Pharmacologic Cardiac Stress Test Agent [EPC]

Package NDCNDC-11Package
71288-201-85712880201851 SYRINGE, PLASTIC in 1 CARTON (71288-201-85) / 5 mL in 1 SYRINGE, PLASTIC

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a550b451-fb30-4c1c-a60e-6e40fba20c88
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=71288-201

Use it

Look up 71288-201 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71288-201 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71288-201. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.